ADIPOQ and breast cancer: Hierarchical clustering, carried out based on protein intensity, highlighted that the identified DEPs can serve as a proteomic signature for distinguishing adiponectin-treated cells vs. control, as well as hormone-responsive vs. hormone-resistant breast cancer mammospheres, as shown by heat map (Figure 3A).